SNSS Financial Facts

Total operating expenses: 9.58M
Net loss: -7.18M
See Full Income Statement

Other accrued liabilities: -4.55M
Deposits and other assets: -61K
See Full Balance Sheet

Sunesis Pharmaceuticals Inc. (SNSS) Earnings

  |   Expand Research on SNSS
Next EPS Date 8/5/14 EPS Growth Rate +5.6%
Average EPS % Beat Rate +1.6% Revenue Growth Rate -33.7%
Average % Move 1-Wk after EPS -2.7% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/5/14 Q214 N/A-$0.17 N/A N/A$1.32M N/A N/A N/A
5/7/14 Q114 -$0.26-$0.17 -$0.09$2M$1.32M N/A Details
3/6/14 Q413 -$0.15-$0.20 +$0.05$2M$1.37M N/A Details
11/12/13 Q313 -$0.16-$0.20 +$0.04$1.99M$1.44M N/A Details
7/29/13 Q213 -$0.18-$0.21 +$0.03$1.99M$1.22M N/A Details
5/9/13 Q113 -$0.23-$0.20 -$0.03$1.99M$750K N/A Details
3/13/13 Q412 -$0.20-$0.19 -$0.01$1.99M$320K N/A Details
11/8/12 Q312 -$0.37-$0.13 -$0.24$265K$4.17M N/A Details